As of 2025-07-06, the Relative Valuation of Seres Therapeutics Inc (MCRB) is 0.89 USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.87 USD, the upside of Seres Therapeutics Inc based on Relative Valuation is -92.5%.
The range of the Relative Valuation is 0.61 - 1.32 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 51.9x | 33.4x |
| Forward P/E multiples | 46.0x - 64.9x | 54.9x |
| Fair Price | 0.61 - 1.32 | 0.89 |
| Upside | -94.9% - -88.9% | -92.5% |
| Date | P/E |
| 2025-07-03 | 601.64 |
| 2025-07-02 | 550.45 |
| 2025-07-01 | 542.59 |
| 2025-06-30 | 563.12 |
| 2025-06-27 | 461.24 |
| 2025-06-26 | 482.02 |
| 2025-06-25 | 482.02 |
| 2025-06-24 | 426.77 |
| 2025-06-23 | 376.09 |
| 2025-06-20 | 375.07 |
| 2025-06-18 | 391.80 |
| 2025-06-17 | 371.02 |
| 2025-06-16 | 380.14 |
| 2025-06-13 | 380.14 |
| 2025-06-12 | 404.98 |
| 2025-06-11 | 407.01 |
| 2025-06-10 | 418.66 |
| 2025-06-09 | 413.09 |
| 2025-06-06 | 417.14 |
| 2025-06-05 | 367.98 |
| 2025-06-04 | 361.39 |
| 2025-06-03 | 354.80 |
| 2025-06-02 | 354.80 |
| 2025-05-30 | 357.33 |
| 2025-05-29 | 359.36 |
| 2025-05-28 | 357.33 |
| 2025-05-27 | 366.46 |
| 2025-05-23 | 388.76 |
| 2025-05-22 | 377.10 |
| 2025-05-21 | 390.28 |
| 2025-05-20 | 417.65 |
| 2025-05-19 | 404.47 |
| 2025-05-16 | 378.11 |
| 2025-05-15 | 375.58 |
| 2025-05-14 | 343.14 |
| 2025-05-13 | 373.55 |
| 2025-05-12 | 399.40 |
| 2025-05-09 | 357.59 |
| 2025-05-08 | 352.52 |
| 2025-05-07 | 420.18 |
| 2025-05-06 | 433.36 |
| 2025-05-05 | 467.83 |
| 2025-05-02 | 488.10 |
| 2025-05-01 | 481.51 |
| 2025-04-30 | 491.65 |
| 2025-04-29 | 476.44 |
| 2025-04-28 | 471.88 |
| 2025-04-25 | 510.91 |
| 2025-04-24 | 460.23 |
| 2025-04-23 | 493.17 |